CIK 0001850270 · <br>Emerging growth company
PROKIDNEY CORP.
Sign in to watch- Ticker
- PROK
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Cayman Islands
- Entity type
- operating
- EIN
- 981586514
- Phone
- 336-999-7028
- Business address
- 2000 FRONTIS PLAZA BLVD., SUITE 250, WINSTON-SALEM, NC, 27103
- Former names
- Social Capital Suvretta Holdings Corp. III
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,067,773
- in 1 filing
Net −$1,067,773. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 27 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-07-12 | Fox Jennifer A. Director | Grant or award · Director stock option (right to buy) | +46,632 | 46,632 | ||
| 2023-07-12 | Fox Jennifer A. Director | Grant or award · Director stock option (right to buy) | +42,515 | 42,515 | ||
| 2023-06-29 | Sinha Uma Director | Grant or award · Director stock option (right to buy) | +48,128 | 48,128 | ||
| 2023-06-29 | Pereira Brian JG Director | Grant or award · Director stock option (right to buy) | +48,128 | 48,128 | ||
| 2023-06-29 | MARAGANORE JOHN Director | Grant or award · Director stock option (right to buy) | +48,128 | 48,128 | ||
| 2023-06-29 | Lotvin Alan Director | Grant or award · Director stock option (right to buy) | +48,128 | 48,128 | ||
| 2023-06-29 | Legorreta Pablo G. Director | Grant or award · Director stock option (right to buy) | +48,128 | 48,128 | ||
| 2023-06-29 | Jimenez Santos Jose Ignacio Director | Grant or award · Director stock option (right to buy) | +48,128 | 48,128 | ||
| 2023-06-29 | DOYLE WILLIAM F Director | Grant or award · Director Stock Option (right to buy) | +48,128 | 48,128 | ||
| 2023-03-31 | Cowen Aaron 10% owner | Other disposition | −3,087,000 | 3,193,175 | ||
| 2023-03-31 | Cowen Aaron 10% owner | Other acquisition | +857,500 | 4,050,675 | ||
| 2023-01-16 | Weger Mary Chief People Officer | Grant or award · Employee stock option (right to buy) | +185,000 | 185,000 | ||
| 2023-01-16 | Weber Darin J. SVP of Regulatory Development | Grant or award · Employee stock option (right to buy) | +250,000 | 250,000 | ||
| 2023-01-16 | McKenzie Libbie Parker Chief Medical Officer | Grant or award · Employee stock option (right to buy) | +250,000 | 250,000 | ||
| 2023-01-16 | Jain Deepak Chief Operating Officer | Grant or award · Employee stock option (right to buy) | +585,000 | 585,000 | ||
| 2023-01-16 | Girolamo Todd C Chief Legal Officer | Grant or award · Employee stock option (right to buy) | +290,000 | 290,000 | ||
| 2023-01-16 | Coulston James Chief Financial Officer | Grant or award · Employee stock option, right to buy | +290,000 | 290,000 | ||
| 2023-01-16 | Bertram Timothy Chief Executive Officer | Grant or award · Employee stock option (right to buy) | +1,011,500 | 1,011,500 | ||
| 2022-12-01 | Weger Mary Chief People Officer | Grant or award · Employee stock option (right to buy) | +450,000 | 450,000 |
Page 9 of 9 · 179 trades